查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585822

乳房病变定位市场：按类型、应用和最终用途分类 - 全球预测 2025-2030

Breast Lesion Localization Methods Market by Type (Electromagnetic Localization, Magnetic Localization, Radioisotope Localization), Usage (Lumpectomy, Mastectomy, Sentinel Lymph Node Identification), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年乳房病变定位市场价值为12亿美元，预计2024年将达到13.9亿美元，复合年增长率为15.74%，预计2030年将达到33.6亿美元。

乳房病变定位市场围绕着用于准确识别和标记乳房组织病变的技术和技术，这对于精确的手术干预和改善患者的治疗效果至关重要。对此类技术的主要需求是由乳癌盛行率的不断增加所驱动的，这需要提高诊断和手术的准确性以提高存活率和患者护理。乳房病灶定位广泛应用于医院、诊所和诊断中心，在乳房保留手术和术前治疗中发挥重要作用，使患者和医疗保健人员受益。由于影像导引立体定位技术和无线方法等技术进步满足了对有效和微创手术日益增长的需求，该市场显示出巨大的成长潜力。关键的成长要素包括早期癌症检测意识的提高、医疗保健基础设施的改善以及对癌症研究的大量投资。然而，监管障碍、先进技术的高成本以及新兴市场进入有限等挑战可能会阻碍市场开拓。

主要市场统计
基准年[2023] 12亿美元
预测年份 [2024] 13.9亿美元
预测年份 [2030] 33.6亿美元
复合年增长率（%） 15.74%

现代商业机会存在于新定位技术的研究和开发中，例如 RFID（无线射频识别）标籤和磁性种子定位。企业应注重策略联盟和伙伴关係关係，以扩大技术力和市场覆盖范围。对微创手术的重视是技术创新的一个有前途的领域，与人工智慧和机器学习技术的整合可以进一步彻底改变早期检测和准确性。市场竞争非常激烈，但产品供应的创新和扩大地理分布（尤其是在新兴市场）将是有益的。洞察表明，持续创新、响应监管变化以及提高成本效率对于成功至关重要。随着以患者为中心的方法变得越来越普遍，对旨在实现可持续成长的市场参与者而言，能够与现有诊断系统无缝整合的改进的本地化技术的需求仍然至关重要。

市场动态：快速发展的乳房病变定位市场的关键市场洞察

供需的动态交互作用正在改变乳房病变定位市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 乳癌发生率上升，乳癌手术数量增加
    • 提高乳癌早期检测意识
    • 政府在乳癌研究上的支出
  • 市场限制因素
    • 监理核准程序的不确定性
  • 市场机会
    • 更多采用技术先进的乳房定位方法
    • 乳房病变无线定位的出现
  • 市场挑战
    • 对肿瘤科医师短缺的担忧

波特五力：驾驭乳房病变定位市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解乳房病变定位市场的外部影响

外部宏观环境因素在塑造乳房病变定位方法市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解乳房病变定位市场的竞争格局

对乳房病变定位方法市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵乳房病变定位市场供应商绩效评估

FPNV定位矩阵是评估乳房病变定位市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与推荐的乳房病变定位方法市场成功之路

对于旨在加强其在全球市场的影响力的公司来说，对乳房病变定位方法市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 乳癌发生率和乳癌手术数量增加
      • 意识提升
      • 政府在乳癌研究上的支出
    • 抑制因素
      • 监理核准流程的不确定性
    • 机会
      • 更多采用技术先进的本地化程序
      • 乳腺病灶无线定位技术的出现
    • 任务
      • 对肿瘤科医师短缺的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章乳房病变定位市场：依类型

  • 电磁定位
  • 磁定位
  • 放射性同位素定位
  • 电线位置

第七章乳房病变定位方法市场（依应用）

  • 切除术
  • 切除术
  • 前哨淋巴结的识别
  • 肿瘤鑑定

第八章乳房病变定位市场：依最终用途

  • 门诊治疗中心
  • 影像诊断中心
  • 医院

第九章北美及南美乳房病变定位市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区乳房病变定位市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲乳房病灶定位市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • BIOPSYBELL SRL
  • CP Medical
  • Cianna Medical, Inc.
  • Cook Group
  • Endomagnetics Limited
  • Hologic, Inc.
  • ILUMARK GmbH
  • Intramedical Imaging
  • Intramedical Imaging, LLC
  • IsoAid, LLC
  • IZI Medical Products by Halma PLC
  • Laurane Medical LLC
  • Merit Medical Systems, Inc.
  • Mermaid Medical
  • Molli Surgical Inc.
  • Ranfac Corp.
  • Sirius Medical System BV
  • SOMATEX Medical Technologies GmbH by Hologic
  • Sterylab Srl
  • Stryker Corporation
  • Wright Medical Group NV
Product Code: MRR-374DB5A06AFC

The Breast Lesion Localization Methods Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 15.74%, to USD 3.36 billion by 2030.

The Breast Lesion Localization Methods market revolves around the techniques and technologies used to accurately identify and mark lesions in breast tissue, crucial for precise surgical interventions and better patient outcomes. The primary necessity for these methods is driven by the increasing prevalence of breast cancer, which demands enhanced diagnostic and surgical precision to improve survival rates and patient care. Widely applied in hospitals, clinics, and diagnostic centers, breast lesion localization plays a critical role in breast-conserving surgeries and pre-operative procedures, benefiting both patients and healthcare providers. The market demonstrates substantial growth potential due to technological advancements such as image-guided localization and wireless methods, addressing the rising demand for effective and minimally invasive techniques. Key growth influencers include the increasing awareness of early cancer detection, improved healthcare infrastructure, and significant funding in cancer research. However, challenges such as regulatory hurdles, high costs of advanced technology, and limited accessibility in developing regions can hinder market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.20 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 3.36 billion
CAGR (%) 15.74%

Latest opportunities exist in the R&D of novel localization techniques like radiofrequency identification (RFID) tags and magnetic seed localization, which promise enhanced accuracy and patient comfort. Companies should focus on strategic collaborations and partnerships to expand their technological capabilities and market reach. The emphasis on minimally invasive procedures presents a promising area for innovation, while integration with AI and machine learning technologies may further revolutionize early detection and precision. Although the market is highly competitive, innovations in product offerings and expanding geographical presence, especially in emerging markets, could be beneficial. Insights show that continuous innovation, keeping pace with regulatory changes, and enhancing cost-efficiency will be vital for success. As patient-centric approaches gain traction, the demand for improved localization technologies that provide seamless integration with existing diagnostic systems remains pivotal for market players aiming towards sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Lesion Localization Methods Market

The Breast Lesion Localization Methods Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of breast cancer and increasing number of breast cancer surgeries
    • Increasing awareness on the early detection of breast cancer
    • Government spending on breast cancer research
  • Market Restraints
    • Uncertainty in regulatory approval procedures
  • Market Opportunities
    • Increasing adoption of technologically advanced localization procedures
    • Emergence of wireless localization of breast lesion
  • Market Challenges
    • Concerns regarding the shortage of oncologists

Porter's Five Forces: A Strategic Tool for Navigating the Breast Lesion Localization Methods Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Lesion Localization Methods Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Lesion Localization Methods Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Lesion Localization Methods Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Lesion Localization Methods Market

A detailed market share analysis in the Breast Lesion Localization Methods Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Lesion Localization Methods Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Lesion Localization Methods Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Lesion Localization Methods Market

A strategic analysis of the Breast Lesion Localization Methods Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Lesion Localization Methods Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, BIOPSYBELL S.R.L., C.P. Medical, Cianna Medical, Inc., Cook Group, Endomagnetics Limited, Hologic, Inc., ILUMARK GmbH, Intramedical Imaging, Intramedical Imaging, LLC, IsoAid, LLC, IZI Medical Products by Halma PLC, Laurane Medical LLC, Merit Medical Systems, Inc., Mermaid Medical, Molli Surgical Inc., Ranfac Corp., Sirius Medical System B.V., SOMATEX Medical Technologies GmbH by Hologic, Sterylab S.r.l., Stryker Corporation, and Wright Medical Group N.V..

Market Segmentation & Coverage

This research report categorizes the Breast Lesion Localization Methods Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Electromagnetic Localization, Magnetic Localization, Radioisotope Localization, and Wire Localization.
  • Based on Usage, market is studied across Lumpectomy, Mastectomy, Sentinel Lymph Node Identification, and Tumor Identification.
  • Based on End-Use, market is studied across Ambulatory Care Centers, Diagnostic Imaging Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of breast cancer and increasing number of breast cancer surgeries
      • 5.1.1.2. Increasing awareness on the early detection of breast cancer
      • 5.1.1.3. Government spending on breast cancer research
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty in regulatory approval procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of technologically advanced localization procedures
      • 5.1.3.2. Emergence of wireless localization of breast lesion
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding the shortage of oncologists
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Breast Lesion Localization Methods Market, by Type

  • 6.1. Introduction
  • 6.2. Electromagnetic Localization
  • 6.3. Magnetic Localization
  • 6.4. Radioisotope Localization
  • 6.5. Wire Localization

7. Breast Lesion Localization Methods Market, by Usage

  • 7.1. Introduction
  • 7.2. Lumpectomy
  • 7.3. Mastectomy
  • 7.4. Sentinel Lymph Node Identification
  • 7.5. Tumor Identification

8. Breast Lesion Localization Methods Market, by End-Use

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Hospitals

9. Americas Breast Lesion Localization Methods Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Breast Lesion Localization Methods Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Breast Lesion Localization Methods Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Argon Medical Devices, Inc.
  • 2. Becton, Dickinson and Company
  • 3. BIOPSYBELL S.R.L.
  • 4. C.P. Medical
  • 5. Cianna Medical, Inc.
  • 6. Cook Group
  • 7. Endomagnetics Limited
  • 8. Hologic, Inc.
  • 9. ILUMARK GmbH
  • 10. Intramedical Imaging
  • 11. Intramedical Imaging, LLC
  • 12. IsoAid, LLC
  • 13. IZI Medical Products by Halma PLC
  • 14. Laurane Medical LLC
  • 15. Merit Medical Systems, Inc.
  • 16. Mermaid Medical
  • 17. Molli Surgical Inc.
  • 18. Ranfac Corp.
  • 19. Sirius Medical System B.V.
  • 20. SOMATEX Medical Technologies GmbH by Hologic
  • 21. Sterylab S.r.l.
  • 22. Stryker Corporation
  • 23. Wright Medical Group N.V.

LIST OF FIGURES

  • FIGURE 1. BREAST LESION LOCALIZATION METHODS MARKET RESEARCH PROCESS
  • FIGURE 2. BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BREAST LESION LOCALIZATION METHODS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BREAST LESION LOCALIZATION METHODS MARKET DYNAMICS
  • TABLE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ELECTROMAGNETIC LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOISOTOPE LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY WIRE LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY LUMPECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MASTECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SENTINEL LYMPH NODE IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TUMOR IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2023